Kolon Life Science Inc. | Ownership
Companies that own Kolon Life Science Inc.
The Vanguard Group, Inc.
173,955
1.52%
4,066
0%
07/31/2018
BlackRock Fund Advisors
96,280
0.84%
0
0%
09/05/2018
BlackRock Advisors (UK) Ltd.
84,559
0.74%
0
0%
09/06/2018
Dimensional Fund Advisors LP
28,541
0.25%
-607
0%
04/30/2018
Norges Bank Investment Management
23,461
0.21%
17,677
0%
12/31/2017
Mirae Asset Global Investments Co., Ltd.
14,964
0.13%
3,587
0.01%
04/30/2018
Korea Investment Management Co., Ltd.
10,806
0.1%
3,679
0.06%
01/31/2018
RAM Active Investments SA
10,727
0.09%
10,727
0.02%
06/30/2017
Charles Schwab Investment Management, Inc.
7,787
0.07%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
4,534
0.04%
0
0%
03/31/2018
Address |
7th Floor, Kolon Tower Annex Gwacheon-si GY 13837 Korea, Republic Of
|
Employees
|
- |
Website |
http://www.kolonls.co.kr |
Updated |
09/14/2018 |
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. It operates through the Pharmaceuticals and Environment Businesses. The Pharmaceutical business provides cell and gene therapeutics. |